Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
Acticor Biotech
588
Acticor Biotech
Technology
Biotechnology
Health Care
Medical
Therapeutics
Acticor Biotech is a company a spin-off from INSERM
Suggest edits
Founded
2013
Raised
$21M
Follow us
Also headquartered in Paris
Ubisoft
Paris
ESA
Orange
BNP Paribas
Ledger
Parrot
Sanofi
IEA
Deezer
Companies in the same industry
Seattle Genetics
Merus
PDC*line Pharma
Confo Therapeutics
DNALite Therapeutics, Inc.
Zucara Therapeutics
X-Biotix Therapeutics
reViral
Lunac Therapeutics
EnClear Therapies
Alexa global traffic share
Overview
Funding
3
Add info
Latest funding
Show all
€15,300,000
Venture capital (Series B) - 2018
CapDecisif Management
Newton Biocapital
Mirae Capital
+2
€1,500,000
Venture capital - 2017
Team Size
2
Employees
I work here
Location
Paris
,
France
Headquarters
Explore Paris
FinSMEs
Acticor Biotech Raises Additional €7M; Closes Series B At €22.3M
€15,300,000
Venture capital (Series B)
FinSMEs
,
PE HUB
Acticor Biotech Raises €15.3M In Series B Financing
Funding
Health
€1,500,000
Venture capital
businesswire
Acticor Biotech Secures €1,5M New Funding from CapDecisif Management
€1,400,000
Venture capital
FinSMEs
Biotechnology Company Acticor Biotech Completes €1.4M Equity Funding
